Benserazide HCl
Active Pharmaceutical Ingredients 2025-03-03
Catalog ID80018042
CAS NO.14919-77-8
Purity 98%
MDL NumberMFCD00078571
Molecular Formula C10H15N3O5.HCl
Molecular Weight 293.7041
Melting point: 146~148℃
| Category | Details |
|---|---|
| Chemical Properties | Molecular formula: C10H16ClN3O5<br> Molecular weight: 286.7 |
| Physical Properties | Appearance: White to off-white crystalline solid<br> Melting point: 146°C<br> Solubility: Soluble in water (35.4 µg/mL at pH 7.4), dimethyl sulfoxide, and methanol; insoluble in ethanol and acetone |
| Mechanism of Action | Inhibits aromatic L-amino acid decarboxylase (AADC), preventing the conversion of L-DOPA to dopamine in the peripheral circulation. This increases the amount of L-DOPA reaching the central nervous system. |
| Therapeutic Uses | Parkinson’s Disease: Used in combination with L-DOPA to enhance its efficacy.<br> Cancer Therapy: Investigated as a cystathionine beta-synthase (CBS) inhibitor to enhance the effectiveness of chemotherapy drugs like paclitaxel. |
| Storage Conditions | Store at 2–8°C. |
| Safety Information | Light-sensitive; protect from light. |
Disclaimer: The above content is for reference and communication only among industry insiders, and does not guarantee its accuracy or completeness. According to relevant laws and regulations and the regulations of this website, units or individuals who purchase related items should obtain valid qualifications and qualification conditions.
